HPV (Human Papillomavirus)-Associated
8
3
3
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
1 terminated out of 8 trials
75.0%
-11.6% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (8)
Parent Education About Human Papillomavirus (HPV)
Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
Multicenter Prospective Non-randomized Controlled Study of Ella Photodynamic Therapy for Cervical HSIL/CIN2
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
The Effect of Natural Molecules on HPV Infection
OPSCC N0 Nodal Control With Reduced IMRT